Find Epoprostenol Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

39 RELATED EXCIPIENT COMPANIES

74EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Flolan, Epoprostenol, Prostacyclin sodium salt, 61849-14-7, Sodium prostacyclin, Prostaglandin i2
Molecular Formula
C20H31NaO5
Molecular Weight
374.4  g/mol
InChI Key
LMHIPJMTZHDKEW-XQYLJSSYSA-M
FDA UNII
4K04IQ1OF4

Epoprostenol Sodium
A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
1 2D Structure

Epoprostenol Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
2.1.2 InChI
InChI=1S/C20H32O5.Na/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22;/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24);/q;+1/p-1/b11-10+,15-8-;/t14-,16+,17+,18+,19-;/m0./s1
2.1.3 InChI Key
LMHIPJMTZHDKEW-XQYLJSSYSA-M
2.1.4 Canonical SMILES
CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)[O-])O2)O)O.[Na+]
2.1.5 Isomeric SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O.[Na+]
2.2 Other Identifiers
2.2.1 UNII
4K04IQ1OF4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Epoprostanol

2. Epoprostenol

3. Epoprostenol Sodium Salt, (5z,9alpha,11alpha,13e,15s)-isomer

4. Flolan

5. Prostacyclin

6. Prostaglandin I(2)

7. Prostaglandin I2

8. Veletri

2.3.2 Depositor-Supplied Synonyms

1. Flolan

2. Epoprostenol

3. Prostacyclin Sodium Salt

4. 61849-14-7

5. Sodium Prostacyclin

6. Prostaglandin I2

7. U-53217a

8. U-53,217a

9. 4k04iq1of4

10. Cyclo-prostin

11. 35121-78-9

12. Epoprostenol Sodium [usan:ban]

13. Ncgc00167427-01

14. Einecs 263-273-7

15. Unii-4k04iq1of4

16. Floran

17. U 53,217a

18. Epoprostenolsodium

19. Prostacyclin Sodium

20. Prostaglandin X Sodium

21. Prostaglandin I2 Na

22. Chembl962

23. Dsstox_cid_26617

24. Dsstox_rid_81769

25. Sodium (5z,13e,15s)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate

26. Dsstox_gsid_46617

27. Schembl41344

28. Sodium (z)-(3ar,4r,5r,6as)-hexahydro-5-hydroxy-4-((e)-(3s)-3-hydroxy-1-octenyl)-2h-cyclopenta(b)furan-delta(sup 2,delta)-valerate

29. Bml1-f10

30. Dtxsid3046617

31. Epoprostenol Sodium [jan]

32. 4ua76

33. Epoprostenol Sodium [usan]

34. Hms1361k18

35. Hms3648l14

36. Epoprostenol Sodium [vandf]

37. Epoprostenol Sodium [mart.]

38. Tox21_112431

39. Epoprostenol Sodium [usp-rs]

40. Epoprostenol Sodium [who-dd]

41. Prostacyclin Sodium Salt [mi]

42. Akos024457370

43. Epoprostenol Sodium [orange Book]

44. Prosta-5,13-dien-1-oic Acid, 6,9-epoxy-11,15-dihydroxy-, Sodium Salt, (5z,9alpha,11alpha,13e,15s)-

45. Cas-61849-14-7

46. Q27259818

47. (5z,13e,8r,9s,11r,12r,15s)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic Acid Sodium Salt

48. Prosta-5,13-dien-1-oic Acid, 6,9-epoxy-11,15-dihydroxy-, Sodium Salt, (5z,9.alpha.,11.alpha.,13e,15s)-

49. Sodium (z)-(3ar,4r,5r,6as)-hexahydro-5-hydroxy-4-((e)-(3s)-3-hydroxy-1-octenyl)-2h-cyclopenta(b)furan-.delta.(sup 2,.delta.)-valerate

50. Sodium (z)-5-((3ar,4r,5r,6as)-5-hydroxy-4-((s,e)-3-hydroxyoct-1-enyl)hexahydro-2h-cyclopenta[b]furan-2-ylidene)pentanoate

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 374.4 g/mol
Molecular Formula C20H31NaO5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count10
Exact Mass374.20691837 g/mol
Monoisotopic Mass374.20691837 g/mol
Topological Polar Surface Area89.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity491
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameEpoprostenol sodium
PubMed HealthEpoprostenol (Injection)
Drug ClassesPeripheral Vasodilator, Platelet Aggregation Inhibitor
Drug LabelEpoprostenol sodium for injection is a sterile sodium salt formulated for intravenous (IV) administration. Each vial of epoprostenol sodium for injection contains epoprostenol sodium equivalent to either 0.5 mg (500,000 ng) or 1.5 mg (1,500,000 ng) e...
Active IngredientEpoprostenol sodium
Dosage FormInjectable
RouteInjection
Strengtheq 1.5mg base/vial; eq 0.5mg base/vial
Market StatusPrescription
CompanyTeva Pharms Usa

2 of 4  
Drug NameFlolan
Drug LabelFLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intravenous (IV) administration. Each vial of FLOLAN contains epoprostenol sodium equivalent to either 0.5mg (500,000ng) or 1.5mg (1,500,000ng) epoprostenol, 3...
Active IngredientEpoprostenol sodium
Dosage FormInjectable
RouteInjection
Strengtheq 1.5mg base/vial; eq 0.5mg base/vial
Market StatusPrescription
CompanyGlaxosmithkline

3 of 4  
Drug NameEpoprostenol sodium
PubMed HealthEpoprostenol (Injection)
Drug ClassesPeripheral Vasodilator, Platelet Aggregation Inhibitor
Drug LabelEpoprostenol sodium for injection is a sterile sodium salt formulated for intravenous (IV) administration. Each vial of epoprostenol sodium for injection contains epoprostenol sodium equivalent to either 0.5 mg (500,000 ng) or 1.5 mg (1,500,000 ng) e...
Active IngredientEpoprostenol sodium
Dosage FormInjectable
RouteInjection
Strengtheq 1.5mg base/vial; eq 0.5mg base/vial
Market StatusPrescription
CompanyTeva Pharms Usa

4 of 4  
Drug NameFlolan
Drug LabelFLOLAN (epoprostenol sodium) for Injection is a sterile sodium salt formulated for intravenous (IV) administration. Each vial of FLOLAN contains epoprostenol sodium equivalent to either 0.5mg (500,000ng) or 1.5mg (1,500,000ng) epoprostenol, 3...
Active IngredientEpoprostenol sodium
Dosage FormInjectable
RouteInjection
Strengtheq 1.5mg base/vial; eq 0.5mg base/vial
Market StatusPrescription
CompanyGlaxosmithkline

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Prostaglandins I [CS]; Vasodilation [PE]; Prostacycline Vasodilator [EPC]
5.3 ATC Code

B - Blood and blood forming organs

B01 - Antithrombotic agents

B01A - Antithrombotic agents

B01AC - Platelet aggregation inhibitors excl. heparin

B01AC09 - Epoprostenol


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"EPOPROSTENOL SODIUM","year":"2021","qtr":"Q1","strtotime":1616783400,"product":"EPOPROSTENOL SODIUM","address":"ACME PLAZA, ANDHERI KURLA ROAD,ANDHERI EAST","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"BOSTON - LOGAN MA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"UNITED STATES","quantity":"268.50","actualQuantity":"268.5","unit":"GMS","unitRateFc":"2484.4","totalValueFC":"660172.8","currency":"USD","unitRateINR":179000,"date":"27-Mar-2021","totalValueINR":"48061500","totalValueInUsd":"660172.8","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9698710","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,ANDHERI EAST, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1660242600,"product":"EPOPROSTENOL SODIUM STAGE-I (REFERENCE S","address":"SPARC TANDALJA","city":"VADODARA","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"BOSTON - LOGAN, MA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"UNITED STATES","quantity":"0.20","actualQuantity":"0.2","unit":"GMS","unitRateFc":"3800","totalValueFC":"716.4","currency":"USD","unitRateINR":285000,"date":"12-Aug-2022","totalValueINR":"57000","totalValueInUsd":"716.4","indian_port":"BOMBAY AIR","hs_no":"29375000","bill_no":"3473163","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"SPARC TANDALJA, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690482600,"product":"EPOPROSTENOL SODIUM","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"TO THE ORDER OF","customerCountry":"JORDAN","quantity":"12.00","actualQuantity":"12","unit":"GMS","unitRateFc":"2000","totalValueFC":"23518.8","currency":"USD","unitRateINR":161083.30875,"date":"28-Jul-2023","totalValueINR":"1932999.705","totalValueInUsd":"23518.8","indian_port":"HYDERABAD AIR","hs_no":"29375000","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694457000,"product":"ITEM CODE : 2021390 HS CODE 29420090 HARMLESS PHARMACEUTICAL BULK DRUG - EPOPROSTENOL SODIUM","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"BOSTON - LOGAN, MA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"UNITED STATES","quantity":"244.50","actualQuantity":"244.5","unit":"GMS","unitRateFc":"1500","totalValueFC":"362927.9","currency":"USD","unitRateINR":123214.72392638036,"date":"12-Sep-2023","totalValueINR":"30126000","totalValueInUsd":"362927.9","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"3878828","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715020200,"product":"EPOPROSTENOL SODIUM","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"MS PHARMA JORDANINJECTABLES","customerCountry":"JORDAN","quantity":"45.00","actualQuantity":"45","unit":"GMS","unitRateFc":"1800","totalValueFC":"80049.8","currency":"USD","unitRateINR":148277.40155555555,"date":"07-May-2024","totalValueINR":"6672483.07","totalValueInUsd":"80049.8","indian_port":"Hyderabad Air","hs_no":"29397900","bill_no":"9695458","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718303400,"product":"EPOPROSTENOL SODIUM STAGE-I : 15-KETO IMPURITY (QTY:30 MGS)","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"BOSTON - LOGAN, MA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"UNITED STATES","quantity":"0.03","actualQuantity":"0.03","unit":"GMS","unitRateFc":"20000","totalValueFC":"543.8","currency":"USD","unitRateINR":1513329.6666666667,"date":"14-Jun-2024","totalValueINR":"45399.89","totalValueInUsd":"543.8","indian_port":"Bombay Air","hs_no":"29375000","bill_no":"1682328","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1727980200,"product":"HARMLESS PHARMACEUTICAL BULK DRUG EPOPROSTENOL SODIUM QTY:77.7 GRAM","address":"ACME PLAZA, ANDHERI KURLA ROAD,","city":"MUMBAI, MAHARASHTRA.","supplier":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","supplierCountry":"INDIA","foreign_port":"BOSTON - LOGAN, MA","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"UNITED STATES","quantity":"77.70","actualQuantity":"77.7","unit":"GMS","unitRateFc":"1198.3","totalValueFC":"91915.4","currency":"USD","unitRateINR":99399.424839124826,"date":"04-Oct-2024","totalValueINR":"7723335.31","totalValueInUsd":"91915.4","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4569360","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ACME PLAZA, ANDHERI KURLA ROAD,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"EPOPROSTENOL SODIUM","year":"2021","qtr":"Q1","strtotime":1612549800,"product":"EPOPROSTENOL SODIUM","address":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"FLAVINE","supplierCountry":"CZECH REPUBLIC","foreign_port":"PRAGUE - RUZYNE","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"0.03","unit":"KGS","unitRateFc":"1975000","totalValueFC":"60565.2","currency":"USD","unitRateINR":"146985000","date":"06-Feb-2021","totalValueINR":"4409550","totalValueInUsd":"60565.2","indian_port":"HYDERABAD AIR","hs_no":"29329990","bill_no":"2660308","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"PRAGUE - RUZYNE","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669573800,"product":"EPOPROSTENOL SODIUM - BATCH# 2209S013 - CAS:61849-14-7 (QTY30 G) 1 X 30 G","address":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,","city":"HYDERABAD,TELANGANA","supplier":"CAYMAN PHARMA S.R.O","supplierCountry":"CZECH REPUBLIC","foreign_port":"NA","customer":"VIATRIS","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"0.03","unit":"KGS","unitRateFc":"1120000","totalValueFC":"35509.2","currency":"EUR","unitRateINR":"96600000","date":"28-Nov-2022","totalValueINR":"2898000","totalValueInUsd":"35509.2","indian_port":"BANGALORE AIR","hs_no":"29375000","bill_no":"3505938","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670524200,"product":"EPOPROSTENOL SODIUM - BATCH# 2209S013 - 20 G,CAS : 61849-14-7 (QTY 20 G)","address":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,","city":"HYDERABAD,TELANGANA","supplier":"CAYMAN PHARMA S.R.O","supplierCountry":"CZECH REPUBLIC","foreign_port":"NA","customer":"VIATRIS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"0.02","unit":"KGS","unitRateFc":"1120000","totalValueFC":"23417.6","currency":"EUR","unitRateINR":"96488000","date":"09-Dec-2022","totalValueINR":"1929760","totalValueInUsd":"23417.6","indian_port":"BANGALORE AIR","hs_no":"29375000","bill_no":"3666424","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706121000,"product":"EPOPROSTENOL SODIUM (QTY:2 X 100 MG, VALUE: USD 2429\/EACH) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CZECH REPUBLIC","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"24290000","totalValueFC":"5356.5","currency":"USD","unitRateINR":"2225943200","date":"25-Jan-2024","totalValueINR":"445188.64","totalValueInUsd":"5356.5","indian_port":"Hyderabad Air","hs_no":"29375000","bill_no":"9835700","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725474600,"product":"EPOPROSTENOL SODIUM BATCH NO: 2407S015 (QTY 260 GRM)","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CAYMAN PHARMA S.R.O","supplierCountry":"CZECH REPUBLIC","foreign_port":"PARANAGUA","customer":"VIATRIS","customerCountry":"INDIA","quantity":"260.00","actualQuantity":"260","unit":"GMS","unitRateFc":"1100","totalValueFC":"320294.8","currency":"EUR","unitRateINR":"103235","date":"05-Sep-2024","totalValueINR":"26841100","totalValueInUsd":"320294.8","indian_port":"Bangalore Air","hs_no":"29375000","bill_no":"5444936","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"PARANAGUA","supplierAddress":"ul Prace 657 27711 Neratovice SDNF SDNF Czech Republic Czech Republic","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734633000,"product":"\\\"FOC\\\" EPOPROSTENOL SODIUM STANDARD - BATCH NO: 2411R01 ( QTY1.4 GRM)\\\"FOC\\\" EPOPROSTENOL SODIUM STANDARD - BATCH NO: 2411R0 ( QTY","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CAYMAN PHARMA S.R.O","supplierCountry":"CZECH REPUBLIC","foreign_port":"PRAGUE - RUZYNE","customer":"VIATRIS","customerCountry":"INDIA","quantity":"1.40","actualQuantity":"1.4","unit":"GMS","unitRateFc":"9424.1","totalValueFC":"13346","currency":"USD","unitRateINR":"810000","date":"20-Dec-2024","totalValueINR":"1134000","totalValueInUsd":"13346","indian_port":"Bangalore Air","hs_no":"29375000","bill_no":"7361959","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"PRAGUE - RUZYNE","supplierAddress":"ul Prace 657 27711 Neratovice SDNF SDNF Czech Republic","customerAddress":"564\/A\/22, ROAD NO.92"}]
06-Feb-2021
20-Dec-2024
GMS
overview
Loading...

Average Price (USD/GMS)

Number of Transactions

Total Quantity (GMS)

Total Value (USD)

Quantity (GMS) & Unit rate (USD/GMS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - EQ 0.5MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 0.5MG BASE/VIAL

USFDA APPLICATION NUMBER - 22260

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 1.5MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 1.5MG BASE/VIAL

USFDA APPLICATION NUMBER - 22260

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Epoprostenol Sodium Manufacturers

A Epoprostenol Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epoprostenol Sodium, including repackagers and relabelers. The FDA regulates Epoprostenol Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epoprostenol Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Epoprostenol Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Epoprostenol Sodium Suppliers

A Epoprostenol Sodium supplier is an individual or a company that provides Epoprostenol Sodium active pharmaceutical ingredient (API) or Epoprostenol Sodium finished formulations upon request. The Epoprostenol Sodium suppliers may include Epoprostenol Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Epoprostenol Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Epoprostenol Sodium USDMF

A Epoprostenol Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Epoprostenol Sodium active pharmaceutical ingredient (API) in detail. Different forms of Epoprostenol Sodium DMFs exist exist since differing nations have different regulations, such as Epoprostenol Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Epoprostenol Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Epoprostenol Sodium USDMF includes data on Epoprostenol Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Epoprostenol Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Epoprostenol Sodium suppliers with USDMF on PharmaCompass.

Epoprostenol Sodium JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Epoprostenol Sodium Drug Master File in Japan (Epoprostenol Sodium JDMF) empowers Epoprostenol Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Epoprostenol Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Epoprostenol Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Epoprostenol Sodium suppliers with JDMF on PharmaCompass.

Epoprostenol Sodium WC

A Epoprostenol Sodium written confirmation (Epoprostenol Sodium WC) is an official document issued by a regulatory agency to a Epoprostenol Sodium manufacturer, verifying that the manufacturing facility of a Epoprostenol Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Epoprostenol Sodium APIs or Epoprostenol Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Epoprostenol Sodium WC (written confirmation) as part of the regulatory process.

click here to find a list of Epoprostenol Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

Epoprostenol Sodium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Epoprostenol Sodium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Epoprostenol Sodium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Epoprostenol Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Epoprostenol Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Epoprostenol Sodium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Epoprostenol Sodium suppliers with NDC on PharmaCompass.

Epoprostenol Sodium GMP

Epoprostenol Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Epoprostenol Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Epoprostenol Sodium GMP manufacturer or Epoprostenol Sodium GMP API supplier for your needs.

Epoprostenol Sodium CoA

A Epoprostenol Sodium CoA (Certificate of Analysis) is a formal document that attests to Epoprostenol Sodium's compliance with Epoprostenol Sodium specifications and serves as a tool for batch-level quality control.

Epoprostenol Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Epoprostenol Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Epoprostenol Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Epoprostenol Sodium EP), Epoprostenol Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epoprostenol Sodium USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty